No Association between Serum Ferritin Levels &gt;10 μg/l and Hair Loss Activity in Women

Bregy, Amadé; Trüeb, Ralph M.

doi:10.1159/000118505

Cited by 64 publications

(53 citation statements)

References 31 publications

(27 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Our data also showed that in AGA patients iron reservoirs were slightly diminished as evidenced by elevated TIBC. Our data in parallel with others' reports indicated that such a hidden iron deficiency could threaten normal hair growth and maintenance and lead to accelerated hair loss and baldness [18][19][20][21][22].…”

Section: Discussionsupporting

confidence: 90%

“…iron deficiency leads to certain kinds of hair loss e.g. female pattern hair loss, telogen effluvium, alopecia areata, alopecia universal [12][13][14][15][16][17], however some researchers denied such claims [18][19][20][21][22]. Clinically iron deficiency is defined either as an increase in total iron binding capacity tion of ferritin under 40 ng/mL [23][24][25].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Androgenetic Alopecia: A Chronic or Pubertal Onset Disease Retarded by Blood Donation

Dayer

Dehghani

Daer³

et al. 2017

Zahedan J Res Med Sci

View full text Add to dashboard Cite

Background: Androgenetic alopecia is the main cause of hair loss and common baldness that affects psychological more than physiological aspects of people's lives. Studies have shown that this multi factorial disorder is initiated by androgens secretion in pubertal period, minerals limitations, autoimmunity, mental stress, genetic predisposition and some alterations in hematological factors. Objectives: The aim of this study was to evaluate the involvement of hematologic parameters in this disease using a case control study design. Methods: In this case-controlled study, two groups each of 80 individuals with androgenetic alopecia were voluntarily included in the study based on their medical histories and clinical examinations and subjected to blood tests for routine hematological parameters. The results were then compared and analyzed using SPSS version 16.0.

show abstract

Section: Discussionsupporting

confidence: 90%

Section: Introductionmentioning

confidence: 99%

Androgenetic Alopecia: A Chronic or Pubertal Onset Disease Retarded by Blood Donation

Dayer

Dehghani

Daer³

et al. 2017

Zahedan J Res Med Sci

View full text Add to dashboard Cite

show abstract

“…9 Also not similar to a cross sectional study by Amade Bregy and Ralph Trueb of total 181 females, where mean age of 22 tellogen effluvium patients was 39.23 years(range,13-60). 5 Data showed that highest percentage patients with telogen effluvium were in the age group 21 to 30 years (50.0%) . This is probably because these age group patients were more concerned about their hair loss.…”

Section: Resultsmentioning

confidence: 94%

“…They found no correlation between ferritin levels<10ìgm/l whether in female pattern hair loss(FPHL) or tellogen effluvium (TE) patients. 5 Although the number of subjects in my study was rather small, a recent case-control study involved just 60 women, in which 34 were patients with hair loss and 26 were healthy control group. Their conclusion was similar to present study in that serum ferritin levels were significantly decreased in telogen effluvium patients compared to control group.…”

Section: Resultsmentioning

confidence: 97%

Low Iron Level is related to Telogen Effluvium in Women

et al. 2013

View full text Add to dashboard Cite

A case-control study conducted in the Department of Dermatology and Venereology of Bangabandhu Sheikh Mujib Medical University, Dhaka from July 2008- December 2010. A total 60 female patients of telogen effluvium attending in outpatient department (OPD) were enrolled in the study with 30 having hair loss considered as case (Group-A) and another 30 females had no history of hair loss were considered as control (Group-B). The study included 60 patients and the mean age were 25.4±7 years ranging from 18 to 42 years in group A and 24.8±5.6 years ranging from 17 to 36 years in group B. Maximum number was found in the age group of 21- 30 years in both groups and nearly three fourth (73.4%) patients were unmarried in group A and 18(60.0%) in group B. Most of the patients were student in both groups, which were 21(70.0%) and 17(56.7%) in group A and group B respectively and majority of the the patients were HSC level in both groups, 15(50.0%) and 14(46.7%) in Group A and Group B respectively. Most of the patients came from middle class, which were 20(66.7%) and 16(53.3%) in group A and group B respectively. The mean serum ferritin were 18.8±8.1 g/L ranging from 4.5 to 36.54 g/L and 36.6±9.9 mg/L ranging from 18.46 to 56.3 mg/ L in group A and group B respectively. The mean Hb level was 11.5±1.4 gm/dl ranging from 8.5 to 14.0 gm/dl in group A and 12.8±1.1 gm/dl ranging from 10.5 to 14.5 gm/dl in group B. The mean difference of Hb level was statistically significant (p<0.05) between two groups in unpaired t-test. It can be concluded that low iron level is associated with telogen effluvium in women. DOI: http://dx.doi.org/10.3329/bjmed.v21i2.13617 Bangladesh J Medicine 2010; 21: 84-89

show abstract

“…The group with serum ferritin less than or equal to 10 ng/mL was too small to draw statistical significance [23].…”

Section: Discussionmentioning

confidence: 91%

Etiological Role of Ferritin and Vitamin D in Patients with Telogen Effluvium

Mohammad¹,

Ibrahium²,

Mohammed³

et al. 2017

J Clin Exp Dermatol Res

View full text Add to dashboard Cite

show abstract

No Association between Serum Ferritin Levels >10 μg/l and Hair Loss Activity in Women

Cited by 64 publications

References 31 publications

Androgenetic Alopecia: A Chronic or Pubertal Onset Disease Retarded by Blood Donation

Androgenetic Alopecia: A Chronic or Pubertal Onset Disease Retarded by Blood Donation

Low Iron Level is related to Telogen Effluvium in Women

Etiological Role of Ferritin and Vitamin D in Patients with Telogen Effluvium

Contact Info

Product

Resources

About